Landmark Studies

CareDx’s landmark studies, including KOAR, SHORE, and AlloMap® and AlloSure® trials, have helped expand the body of evidence in transplant diagnostics. With thousands of patients and dozens of centers worldwide, this research contributes to the peer-reviewed science used by clinicians and researchers to evaluate and refine approaches to transplant care. Explore our research highlights, real-world findings, and published evidence behind our work.

Advancing the Evidence Behind Transplant Monitoring

Overview of Landmark Studies

Continuing to Build Evidence for Transplant Monitoring Assays

CELL THERAPY Predict Post-Transplant Relapse Surveillance Outcomes Treatment Response LUNG Surveillance Outcomes Subclinical Rejection All Transplant Coverage KIDNEY Procedure Decision Making Treating Subclinical Rejection 3-year Survival HEART Survival outcomes Prognostic value Patient risk stratification GENERATING EVIDENCE ACROBAT ALAMO KOAR OKRA SHORE PRIMARY STUDY 307 patients 2-year follow-up 11 sites 550 patients 3-year follow-up 22 sites, ALRTS protocol >3,600 patients 3-year follow-up 56 sites, ARTS protocol >2,700 patients 5-year follow-up 67 sites STUDY COMPOSITION

Key Facts & Figures

Full List of Publications & Peer-Reviewed Evidence

View all publications
VTS-PRO-11245-v1 2026.01